Matches in SemOpenAlex for { <https://semopenalex.org/work/W4315705426> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W4315705426 endingPage "e357" @default.
- W4315705426 startingPage "e357" @default.
- W4315705426 abstract "Objective: Previously, we have found that Losartan (5∼50 μM), an AT1 receptor blocker, dose-dependently inhibits secretion of catecholamines (CA) evoked by cholinergic and angiotensin II (Ang II) receptor stimulation from the perfused rat adrenal medulla. The aim of the present study was to examine the characteristic effects of high-dose losartan on the CA secretion from the isolated perfused rat adrenal gland, and also to establish its mechanism of action. Design and Methods: The adrenal gland was isolated and perfused with Krebs-bicarbonate. CA was measured directly by using the fluorospectrophotometer. Results: The perfusion of high-dose losartan (150 ∼ 600 μM) into an adrenal vein for 90 min resulted in great increases in CA secretions evoked by acetylcholine in a dose-dependent fashion. Also, losartan (300 μM) enhanced the CA release evoked by Ang II, high K+ and DMPP (a selective nicotinic receptor agonist), McN-A-343 (a selective muscarinic M1 receptor agonist). Also, in the presence of losartan (300 μM), the CA secretory responses to veratridine (a selective Na+ channel activator), Bay-K-8644 (a Ca2+ channel activator), and cyclopiazonic acid (a cytoplasmic Ca2+-ATPase inhibitor) were significantly potentiated, respectively. The facilitatory CA-releasing effect of Ach evoked by high-dose losartan (300 μM) was time-dependently depressed by pretreatment with nifedipine (Ca2+ channel blocker), while not by pretreatment with sodium nitroprusside (an NO donor). High-dose olmesartan (150 ∼ 600 μM), one of ARBs, also potentiated Ach-evoked CA release in time-dependent fashion. However, in the simultaneous presence of losartan (300 μM) and CGP42112 (an AT2 receptor agonist), the facilitatory responses of losartan on the CA secretion evoked by ACh were rather significantly reduced in comparison with that of losartan-treatment alone. Conclusion: Conclusively, these results demonstrate that high-dose losartan can potentiate the adrenomedullary CA secretion in a calcium-dependent fashion. It seems that this facilitatory effect of high-dose losartan may be mediated by activation of the Ca2+ influx through L-type Ca2+ channels into adrenomedullary cells without inhibition of NO synthesis, which seems to be relevant to AT2 receptor blockade. It also suggests that high-dose ARBs may be a risk factor in causing hypertensive response." @default.
- W4315705426 created "2023-01-12" @default.
- W4315705426 creator A5003087406 @default.
- W4315705426 creator A5020379551 @default.
- W4315705426 creator A5072342317 @default.
- W4315705426 date "2023-01-01" @default.
- W4315705426 modified "2023-10-02" @default.
- W4315705426 title "PS-B03-5: HIGH-DOSES OF LOSARTAN RATHER ENHANCE CATECHOLAMINE SECRETION FROM THE PERFUSED ADRENAL GLAND" @default.
- W4315705426 doi "https://doi.org/10.1097/01.hjh.0000916404.04764.bd" @default.
- W4315705426 hasPublicationYear "2023" @default.
- W4315705426 type Work @default.
- W4315705426 citedByCount "0" @default.
- W4315705426 crossrefType "journal-article" @default.
- W4315705426 hasAuthorship W4315705426A5003087406 @default.
- W4315705426 hasAuthorship W4315705426A5020379551 @default.
- W4315705426 hasAuthorship W4315705426A5072342317 @default.
- W4315705426 hasBestOaLocation W43157054261 @default.
- W4315705426 hasConcept C104849204 @default.
- W4315705426 hasConcept C123915805 @default.
- W4315705426 hasConcept C126322002 @default.
- W4315705426 hasConcept C134018914 @default.
- W4315705426 hasConcept C153461711 @default.
- W4315705426 hasConcept C170493617 @default.
- W4315705426 hasConcept C2775894120 @default.
- W4315705426 hasConcept C2777387769 @default.
- W4315705426 hasConcept C2777597313 @default.
- W4315705426 hasConcept C2779996123 @default.
- W4315705426 hasConcept C2780288358 @default.
- W4315705426 hasConcept C2908929049 @default.
- W4315705426 hasConcept C519063684 @default.
- W4315705426 hasConcept C71924100 @default.
- W4315705426 hasConcept C84393581 @default.
- W4315705426 hasConceptScore W4315705426C104849204 @default.
- W4315705426 hasConceptScore W4315705426C123915805 @default.
- W4315705426 hasConceptScore W4315705426C126322002 @default.
- W4315705426 hasConceptScore W4315705426C134018914 @default.
- W4315705426 hasConceptScore W4315705426C153461711 @default.
- W4315705426 hasConceptScore W4315705426C170493617 @default.
- W4315705426 hasConceptScore W4315705426C2775894120 @default.
- W4315705426 hasConceptScore W4315705426C2777387769 @default.
- W4315705426 hasConceptScore W4315705426C2777597313 @default.
- W4315705426 hasConceptScore W4315705426C2779996123 @default.
- W4315705426 hasConceptScore W4315705426C2780288358 @default.
- W4315705426 hasConceptScore W4315705426C2908929049 @default.
- W4315705426 hasConceptScore W4315705426C519063684 @default.
- W4315705426 hasConceptScore W4315705426C71924100 @default.
- W4315705426 hasConceptScore W4315705426C84393581 @default.
- W4315705426 hasIssue "Suppl 1" @default.
- W4315705426 hasLocation W43157054261 @default.
- W4315705426 hasLocation W43157054262 @default.
- W4315705426 hasOpenAccess W4315705426 @default.
- W4315705426 hasPrimaryLocation W43157054261 @default.
- W4315705426 hasRelatedWork W1844072728 @default.
- W4315705426 hasRelatedWork W1965773147 @default.
- W4315705426 hasRelatedWork W1966165595 @default.
- W4315705426 hasRelatedWork W1976633810 @default.
- W4315705426 hasRelatedWork W1998162485 @default.
- W4315705426 hasRelatedWork W2030755374 @default.
- W4315705426 hasRelatedWork W2107775757 @default.
- W4315705426 hasRelatedWork W2339854003 @default.
- W4315705426 hasRelatedWork W2397870085 @default.
- W4315705426 hasRelatedWork W56955019 @default.
- W4315705426 hasVolume "41" @default.
- W4315705426 isParatext "false" @default.
- W4315705426 isRetracted "false" @default.
- W4315705426 workType "article" @default.